Concepedia

Franklin Igwe

FI

6

Publications

102

Citations

6

H-Index

2017

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

Doheny Eye Institute

Illinois Retina Associates

Novartis (United Kingdom)

Franklin Igwe is an author at Novartis (Switzerland) specializing in glaucoma, ophthalmology, and medicine.

Top concepts

Publications per year

2017–2024

6

Publications

6

Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study

Richard Gale, Ian Pearce, Nicole Eter et al. · British Journal of Ophthalmology · 2019 · 28 citations · Full text

Resource Use and Real-World Outcomes for Ranibizumab Treat and Extend for Neovascular Age-Related Macular Degeneration in the UK: Interim Results from TERRA

Yit C. Yang, Louise Downey, Hemal Mehta et al. · Ophthalmology and Therapy · 2017 · 19 citations · Full text

One-Year Brolucizumab Outcomes in Neovascular Age-Related Macular Degeneration from a Large United States Cohort in the IRIS® Registry

Mathew W. MacCumber, Charles C. Wykoff, Hélène Karcher et al. · Ophthalmology · 2023 · 18 citations

, , +7

Real-World Safety Outcomes with Brolucizumab in Neovascular Age-Related Macular Degeneration: Findings from the IRIS® Registry

Marco A. Zarbin, Mathew W. MacCumber, Hélène Karcher et al. · Ophthalmology and Therapy · 2024 · 15 citations · Full text

Factors Linked to Injection Interval Extension in Eyes with Wet Age-Related Macular Degeneration Switched to Brolucizumab

Mathew W. MacCumber, Charles C. Wykoff, Hélène Karcher et al. · Ophthalmology · 2023 · 12 citations

Rows per page

1–5 of 6